Flexible Endoscopes Companies

The flexible endoscopes market is projected to reach USD 3.07 billion by 2030, growing from USD 2.38 billion in 2025, at a CAGR of 5.1% from 2025 to 2030.

The flexible endoscopes market is growing due to the rising demand for minimally invasive procedures, increasing prevalence of gastrointestinal and respiratory disorders, and technological advancements enhancing image quality and maneuverability. Moreover, the expanding geriatric population and improved reimbursement policies further drive adoption. However, market growth is expected to be restrained by high device costs, risk of cross-contamination despite reprocessing, and the availability of alternative diagnostic techniques. Additionally, a lack of skilled professionals and regulatory challenges further hamper the growth of the market.

Some of the major players in the flexible endoscopes market are Olympus Corporation (Japan), Karl Storz SE & CO. Kg (Germany), Boston Scientific Corporation (US), FujiFilm Corporation (Japan), Hoya Corporation (Japan), and others. These players have incorporated various organic and inorganic growth strategies, including acquisitions, product launches, product approvals, and partnerships, to strengthen their international footprint and capture a significant share of the flexible endoscopes market. These organic and inorganic strategies have allowed them to expand across geographies by offering flexible endoscope products.

To know about the assumptions considered for the study download the pdf brochure

In May 2025, Olympus Corporation (Japan) announced an FDA 510 (k) clearance for its EZ1500 series endoscopes, which incorporate Extended Depth of Field (EDOF) technology to enhance visualization and diagnostic precision.

In January 2025, Karl Storz SE & CO. Kg (Germany) announced the strategic acquisition of its long-standing Swiss distributor, ANKLIN, to strengthen its direct sales presence in Switzerland. This move enhanced customer proximity and supported the company’s tailored product and service delivery in the MedTech sector.

In January 2024, Olympus Corporation (Japan) acquired Taewoong Medical Co., Ltd., a Korea-based manufacturer of medical devices. This acquisition helped Olympus strengthen its GI Endo Therapy product portfolio capabilities, contribute to improving patient outcomes through comprehensive solutions, and elevate the standard of care.

In May 2023, Olympus Corporation (Japan) announced the launch of two bronchoscopes under the EVIS X1 Endoscopy System, representing its latest diagnostic and therapeutic technology advancement.

Other prominent players operating in the market include Nipro (Japan), EndoMed Systems GmbH (Germany), Richard Wolf GmbH. (Germany), and Ambu A/S (Denmark), and among others.

Olympus Corporation (US)

Olympus Corporation is a leading player in the flexible endoscopes market due to its comprehensive and diversified portfolio of advanced endoscopy equipment and services, including gastrointestinal and surgical flexible endoscopes supported by integrated endoscopic systems and repair solutions. The company’s strong global presence, comprising 89 subsidiaries and 3 affiliates, ensures broad market access across Japan, North America, Europe, Asia & Oceania, China, and other global markets. Olympus consistently delivers high-performance, clinically efficient solutions across multiple therapeutic areas. This makes it a preferred partner for healthcare providers worldwide. Additionally, its dual organic and inorganic growth strategy further reinforces its leadership.

Olympus invests heavily in innovation, as was demonstrated by the launch of two new bronchoscopes in May 2023. The new bronchoscopes are integrated with AI to enhance diagnostic precision and procedural efficiency. Additionally, the company pursues strategic acquisitions and distribution agreements to expand product offerings and market reach. These initiatives support sustained technological advancements, increased adoption among end users, and a competitive market position. By integrating advanced imaging, enhanced maneuverability, and reprocessing technologies, Olympus delivers customer-centric solutions that support precision diagnostics and minimally invasive interventions, securing its dominant role in the global flexible endoscopes market.

Karl Storz SE & CO. Kg (Germany)

Karl Storz SE & Co. Kg is a leading player in the flexible endoscopes market due to its comprehensive portfolio of over 10,000 high-precision human and veterinary medicine products. The company’s advanced flexible endoscopy solutions span key clinical applications, such as bronchoscopy, laryngoscopy, and neuroendoscopy. These applications reinforce its position in critical medical disciplines. Operating through 70 subsidiaries in more than 50 countries and maintaining production facilities in Germany, the US, Switzerland, Estonia, and China, the company ensures a robust global footprint that effectively addresses diverse regional healthcare needs. The company’s presence across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa facilitates customer engagement and reliable service delivery. To cement its position in the market, Karl Storz adopts strategic inorganic growth initiatives.

An example of this can be the acquisition of Surgical, Inc. (US) in August 2024, to expand its advanced surgical and endoscopic offerings. Additionally, the company’s collaboration with FUJIFILM Corporation for the joint marketing of GI endoscopes and OR integration systems further enhanced its technological capabilities and market presence. Karl Storz remains a trusted and influential force in the global flexible endoscopes market through innovation, strategic partnerships, and operational reach.

Market Ranking

The ranking of firms in the flexible endoscopes market is based on the market share analysis of these players, secondary research, and validation from primary respondents. The rating also considers revenue of these players, breadth and depth of their product portfolios, innovation, and approvals/launches. The flexible endoscopes market is competitive, with three players, namely Olympus Corporation (Japan), Karl Storz SE & Co. Kg (Germany), and Boston Scientific Corporation (US) collectively accounting for  25%­–50% of the total market share.

Olympus Corporation (Japan) stands out for its diverse portfolio of advanced flexible endoscopes. The company continuously uses organic strategies to maintain its position in the market. Karl Storz SE & CO. Kg (Germany) maintains a strong global presence with its advanced portfolio of endoscopes. Boston (US) stands out for its significant diverse portfolio globally. FUJIFILM Corporation (Japan) and HOYA Corporation (Japan) offer advanced flexible endoscopes.

Related Reports:

Flexible Endoscopes Market by Type (Colonoscope, Laryngoscope, Bronchoscope, Other Types), Application (Laparoscopy, Mediastinoscopy, Obstetrics, Arthroscopy, Cystoscopy, Mediastinoscopy), End User (Hospitals, ASCs, Clinics), and Region – Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com